VKH
ORMP icon

Virtu KCG Holdings’s Oramed Pharmaceuticals ORMP Stock Holding History

Virtu KCG Holdings’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$125K Buy
+16,077
New +$121K ﹤0.01% 2353
2017
Q1 		– Sell
-13,910
Closed -$85K – 3570
2016
Q4 		$85K Buy
+13,910
New +$90.6K ﹤0.01% 2963
2015
Q1 		– Sell
-14,353
Closed -$65K – 3677
2014
Q4 		$65K Buy
+14,353
New +$94.4K ﹤0.01% 3361

Other funds holding ORMP

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Virtu KCG Holdings's ORMP Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2017: 16,077 shares worth $125K. The stake represents ﹤0.01% of the portfolio and ranks #2353 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ORMP as recently as Q4 2016.

Virtu KCG Holdings first reported a position in ORMP in Q4 2014 and has held it in 3 quarters since. 23 funds tracked by Wall St. Rank hold ORMP as of Q2 2017.

  • Virtu KCG Holdings held 16,077 shares of Oramed Pharmaceuticals worth $125K as of Q2 2017.
  • Oramed Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Oramed Pharmaceuticals made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2353 holding.
  • Virtu KCG Holdings first reported a position in Oramed Pharmaceuticals in Q4 2014 and has held it in 3 quarters since.
  • 23 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.